Clinical Trial Update: Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Lactobacillus reuteri to prevent antibiotic-associated diarrhea and Clostridioides difficile infection in hospitalized children. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea
• Clostridioides Difficile Infection
• Gastroenteritis

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: St Marina University Hospital, Varna, Bulgaria | Conditions: Antibiotic Associated Diarrhea, Clostridium Difficile Infection | Phase 3 | Status: COMPLETED